National	national	O	O	O	O
project	project	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
prevention	prevention	O	O	O	O
of	of	O	O	O	O
mother-to-infant	mother-to-infant	O	O	O	O
infection	infection	O	DISEASE	OTHERS	I
by	by	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
virus	virus	O	O	OTHERS	I
in	in	O	O	O	O
Japan	japan	O	O	O	O
.	.	O	O	O	O
In	in	O	O	O	O
Japan	japan	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
nationwide	nationwide	O	O	O	O
prevention	prevention	O	O	O	O
program	program	O	O	O	O
against	against	O	O	O	O
mother-to-infant	mother-to-infant	O	O	O	O
infection	infection	O	DISEASE	OTHERS	I
by	by	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
virus	virus	O	O	OTHERS	I
(	(	O	O	O	O
HBV	hbv	O	O	O	O
)	)	O	O	O	O
started	started	O	O	O	O
in	in	O	O	O	O
1985	1985	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
program	program	O	O	O	O
consists	consists	O	O	O	O
of	of	O	O	O	O
double	double	O	O	O	O
screenings	screenings	O	O	O	O
of	of	O	O	O	O
pregnant	pregnant	O	O	O	O
women	women	O	O	O	O
and	and	O	O	O	O
prophylactic	prophylactic	O	O	O	O
treatment	treatment	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
infants	infants	O	O	O	O
born	born	O	O	O	O
to	to	O	O	O	O
both	both	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
surface	surface	O	O	OTHERS	I
antigen	antigen	O	O	OTHERS	I
(	(	O	O	O	O
HBsAg	hbsag	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
e	e	O	O	OTHERS	I
antigen	antigen	O	O	OTHERS	I
(	(	O	O	O	O
HBeAg	hbeag	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
positive	positive	O	O	O	O
mothers	mothers	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
infants	infants	O	O	O	O
are	are	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
two	two	O	O	O	O
injections	injections	O	O	O	O
of	of	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
immune	immune	O	O	O	O
globulin	globulin	O	O	O	O
(	(	O	O	O	O
HBIG	hbig	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
least	least	O	O	O	O
three	three	O	O	O	O
injections	injections	O	O	O	O
of	of	O	O	O	O
plasma	plasma	O	O	O	O
derived	derived	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
vaccine	vaccine	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
sent	sent	O	O	O	O
questionnaires	questionnaires	O	O	O	O
about	about	O	O	O	O
the	the	O	O	O	O
numbers	numbers	O	O	O	O
of	of	O	O	O	O
each	each	O	O	O	O
procedure	procedure	O	O	O	O
or	or	O	O	O	O
examination	examination	O	O	O	O
during	during	O	O	O	O
nine	nine	O	O	O	O
months	months	O	O	O	O
of	of	O	O	O	O
investigation	investigation	O	O	O	O
period	period	O	O	O	O
to	to	O	O	O	O
each	each	O	O	O	O
local	local	O	O	O	O
government	government	O	O	O	O
in	in	O	O	O	O
1986	1986	O	O	O	O
and	and	O	O	O	O
1987	1987	O	O	O	O
.	.	O	O	O	O

93.4	93.4	O	O	O	O
%	%	O	O	O	O
pregnant	pregnant	O	O	O	O
women	women	O	O	O	O
had	had	O	O	O	O
the	the	O	O	O	O
chance	chance	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
examined	examined	O	O	O	O
for	for	O	O	O	O
HBsAg	hbsag	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
positive	positive	O	O	O	O
rate	rate	O	O	O	O
was	was	O	O	O	O
1.4	1.4	O	O	O	O
to	to	O	O	O	O
1.5	1.5	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
HBeAg	hbeag	CHEMICALS	O	OTHERS	I
positive	positive	O	O	O	O
rate	rate	O	O	O	O
in	in	O	O	O	O
HBsAg	hbsag	CHEMICALS	O	OTHERS	I
positive	positive	O	O	O	O
was	was	O	O	O	O
23	23	O	O	O	O
to	to	O	O	O	O
26	26	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
HBsAg	hbsag	CHEMICALS	O	OTHERS	I
positive	positive	O	O	O	O
rate	rate	O	O	O	O
in	in	O	O	O	O
neonates	neonates	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
infants	infants	O	O	O	O
before	before	O	O	O	O
two	two	O	O	O	O
months	months	O	O	O	O
were	were	O	O	O	O
3	3	O	O	O	O
%	%	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
%	%	O	O	O	O
respectively	respectively	O	O	O	O
.	.	O	O	O	O

Some	some	O	O	O	O
problems	problems	O	O	O	O
may	may	O	O	O	O
arise	arise	O	O	O	O
,	,	O	O	O	O
because	because	O	O	O	O
27	27	O	O	O	O
to	to	O	O	O	O
30	30	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
infants	infants	O	O	O	O
need	need	O	O	O	O
the	the	O	O	O	O
fourth	fourth	O	O	O	O
vaccination	vaccination	O	O	O	O
in	in	O	O	O	O
some	some	O	O	O	O
restricted	restricted	O	O	O	O
areas	areas	O	O	O	O
.	.	O	O	O	O

